We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalised lists.
Financial calendars – Yahoo Finance
Prev
- 3NovSun1 Stock splits4 Economic events
- 4NovMon1 Earnings18 Stock splits7 IPO pricing40 Economic events
- 5NovTues42 Stock splits3 IPO pricing41 Economic events
- 6NovWed25 Stock splits1 IPO pricing39 Economic events
- 7NovThu2 Earnings17 Stock splits6 IPO pricing64 Economic events
- 8NovFri3 Earnings20 Stock splits12 IPO pricing76 Economic events
- 9NovSat
Next
Motley FoolMeet 3 Supercharged Growth Stocks That Could Profit From a Trump Presidency, According to Certain Wall Street Analysts
The much-ballyhooed "Red Wave" came to pass. There are several high-profile stocks poised to profit.
Motley FoolAltria's Shares Rallied, but Is the Stock a Buy?
Altria's stock is up by more than 30% over the past year, with a recent, and sizable, post-earnings jump. Is it worth this price?
PR NewswireLayne's Chicken Fingers Celebrating New Pasadena Location with Grand Opening in December
Layne's Chicken Fingers, the fan-favorite chicken franchise out of Texas, is coming to Pasadena. Opening this December at 5000 Fairmont Pkwy, the new location will give Pasadena residents a chance to find out what has made Layne's an iconic name in Texas. (Hint: chicken fingers don't get much crispier than these.)
Simply Wall St.Are Simonds Group Limited's (ASX:SIO) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
It is hard to get excited after looking at Simonds Group's (ASX:SIO) recent performance, when its stock has declined...
Simply Wall St.Returns On Capital Signal Tricky Times Ahead For Brickworks (ASX:BKW)
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Simply Wall St.ANZ Group Holdings Full Year 2024 Earnings: EPS Beats Expectations
ANZ Group Holdings ( ASX:ANZ ) Full Year 2024 Results Key Financial Results Revenue: AU$20.1b (flat on FY 2023). Net...
Motley Fool1 Stock Down 63% to Buy Right Now
The price keeps rising, but the valuation still looks reasonable.
GlobeNewswireALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)
ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (“ARS Pharma”, NASDAQ: SPRY). The agreement grants ALK exclusive global rights to the neffy® adrenaline (epinephrine) nasal spray, with exception of the USA, Australia, New Zealand, Japan and China. The deal delivers on key elements in ALK’s new strategy Allergy+ and supports ALK’s long-term financial ambitions. Needle-free, nasal delivery of adrenaline has th
Simply Wall St.Favourable Signals For Schaffer: Numerous Insiders Acquired Stock
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Motley Fool1 of the Biggest Reasons Behind Estée Lauder Stock's Plunge
The company made a big bet on a fast-growing international market that has taken a turn for the worse.